🇺🇸 FDA
Pipeline program

misoprostol

DMR95-IRB-116

Phase 3 small_molecule completed

Quick answer

misoprostol for Labor Induction is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Labor Induction
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials